Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model
Ran Guo et al, 2024, European Radiology Experimental CrossRef
Network Pharmacology Study on the Pharmacological Mechanism of Cinobufotalin Injection against Lung Cancer
Yun Mao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
Han-yu Jiang et al, 2022, OncoTargets and Therapy CrossRef
Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
Lai Wei et al, 2022, Chinese Medicine CrossRef
An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
Laura Soumoy et al, 2024, Cancer Cell International CrossRef
The Integrated Study on the Chemical Profiling to Explore the Constituents and Mechanism of Traditional Chinese Medicine Preparation Huatuo Jiuxin Pills Based on UPLC-Q-TOF/MSE and Network Pharmacology
Yulong Zhu et al, 2022, Frontiers in Molecular Biosciences CrossRef
Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment
Eva Juengel et al, 2021, Biomedicines CrossRef
Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology
Jianbo Zhou et al, 2022, Frontiers in Pharmacology CrossRef
Influence of Different Ratios of DSPE-PEG2k on Ester Prodrug Self-Assembly Nanoparticles for Cell Migration and Proliferation Suppression
Huiyun Zhang et al, 2024, International Journal of Nanomedicine CrossRef